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White matter hyperintensities (WMHs) and brain atrophy often coexist in the elderly.
Additionally, WMH is often observed as occipital periventricular hyperintensities (OPVHs)
with low-grade periventricular (PV) white matter (WM) lesions and is usually confined
within an anatomical structure. However, the effects of OPVHs on gray matter (GM)
atrophy remain largely unknown. In this study, we investigated GM atrophy in OPVHs
patients and explored the relationship between such atrophy and clinical risk factors.
T1-weighted and T2-weighted Magnetic resonance imaging (MRI) were acquired, and
voxel-based morphometry (VBM) analysis was applied. The clinical (demographic and
cardiovascular) risk factors of the OPVHs patients and healthy controls were then
compared. Lastly, scatter plots and correlation analysis were applied to explore the
relationship between the MRI results and clinical risk factors in the OPVHs patients.
OPVHs patients had significantly reduced GM in the right supramarginal gyrus, right
angular gyrus, right middle temporal gyrus, right anterior cingulum and left insula
compared to healthy controls. Additionally, OPVHs patients had GM atrophy in the left
precentral gyrus and left insula cortex, and such atrophy is associated with a reduction
in low-density lipoprotein cholesterol (LDL-C) and apolipoprotein-B (Apo-B).
Keywords: magnetic resonance imaging, occipital periventricular hyperintensities, voxel-based morphometry
analysis, gray matter atrophy, LDL-C
INTRODUCTION
Whitematter hyperintensities (WMHs) and brain atrophy often coexist in the elderly. Furthermore,
WMHs can be divided into paraventricular WMHs (PVHs) and deep white matter hyperintensities
(DWMHs; Katsumata et al., 2010). Previous studies have suggested that PVHs and DWMHs
have different clinical and pathological features with PVHs related to brain atrophy and DWMHs
related to cerebrovascular diseases (Barber et al., 2000). It should be noted that the degree
of cognitive impairment associated with WMHs also depends on the volume and location
of the lesions, as well as other factors such as brain reserve (Brickman et al., 2011; Murray
et al., 2011; Smith et al., 2011; Hulst et al., 2013). Additionally, the impact of WMHs location
is often assessed by dividing the brain into different regions, e.g., the occipital, temporal,
frontal and parietal lobes, as well as the basal ganglia and infratentorial region. In particular,
WMH is often observed as occipital periventricular hyperintensities (OPVHs) with low-grade
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periventricular (PV) WM lesions and is usually confined within
an anatomical structure. However, the effects of OPVHs on gray
matter (GM) atrophy remain largely unknown.
Magnetic resonance imaging (MRI) is a non-invasive medical
imaging technique that can detect WMHs using T1-weighted
and T2-weighted images. Voxel-based morphometry (VBM)
analysis was recently developed to increase the sensitivity of
MRI in the investigation of focal differences in brain anatomy
using Statistical parametric mapping (SPM). In this study, we
investigated GM atrophy in OPVHs patients using T1-weighted
and T2-weighted MRI with VBM analysis. Additionally, the
clinical (demographic and cardiovascular) risk factors of the
OPVHs patients and healthy controls were compared. Lastly, we
explored the relationship between the MRI results and clinical
risk factors in OPVHs patients.
MATERIALS AND METHODS
Subjects
Patients with OPVHs (n = 97) and healthy controls (n = 73)
underwent MRI scanning between 2012 July and 2015 July
in the Department of Neurology in Xinqiao Hospital, Third
Military Medical University. The subjects (age range: 55–85
years old) were restricted from vitamin 12 intake for 3 months
prior to scanning. It should be noted that subjects with other
diseases leading to white matter (WM) lesions, such as multiple
sclerosis, toxic cerebral WM lesions, progressive multifocal
leukoencephalopathy, atrial fibrillation and thyroid disease,
were excluded from the study. Additionally, cerebrovascular
disease induced by heart and aorta embolism, atrial fibrillation,
valvulopathy, endocarditis, myocardiopathy, left atrioventricular
valve stenosis or ventricular aneurysm, vasculitis, familial
high homocysteine, infectious diseases, anemia or malignant
disease, intracranial tumors, any systemic diseases, receiving
special treatment such as radiotherapy, drug chemotherapy and
biological therapy, as well as immune system diseases such as
connective tissue or autoimmunity diseases, were also excluded
from the study. It should be noted that OPVHs patients have
OPVHs ≥1 according to the Fazekas scale. Additionally, the
patients did not have lesions in other locations, and the healthy
controls (CN) had no WMHs in any location of the brain. This
study was approved by the medical ethics committee of Xinqiao
Hospital, Third Military Medical University, Chongqing, China.
Full written informed consent for participation was obtained
from each subject.
The gender (Gen), age, hypertension (Htn) and diabetes
mellitus (DM) history, current smoking (CS) and current
alcohol use (CAU) were obtained from the patient-administered
questionnaire. Total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), triglycerides (TG), uric acid (UA), apolipoprotein-A1
(Apo-A1) and apolipoprotein-B (Apo-B) were also measured.
MRI Protocols
All MRI data were obtained using a 3.0 Tesla scanner
(General Electric, Milwaukee, WI, USA) with a 12-channel
head coil. Fast spin-echo (FSE) T2-weighted images and
fluid attenuation inversion recovery (FLAIR) T1-weighted
images were acquired with TE/TR = 112.2/3160 ms
and TE/IT/TR = 27.072/860/1696.68 ms, respectively.
All MRI images were acquired with a voxel size of
0.4688 × 0.4688 × 5 mm3, 20 sagittal slices and an in-plane
resolution of 512 × 512. MRI images were then assessed visually
by two neurologists using the Fazekas scale (Fazekas et al., 1987).
Note that all subjects had no cerebral infarcts defined as focal
hyperintensities in T2 images.
Data Analysis
All statistical analyses of Demographic and clinical variables were
performed using SPSS20 (IBMSPSS, Chicago, IL, USA). Data are
presented as the means (standard deviation). Chi-square test and
Student’s t-test were used to determine significant differences
of the frequencies of categories and differences in continuous
variables, respectively, between the groups.
The MRI data were processed using the SPM8 (Welcome
Department of Imaging Neuroscience Group, London, UK1)
with VBM implemented in the VBM8 toolbox2. Images were
bias-corrected, tissue-classified and registered (Ashburner and
Friston, 2005). Subsequently, VBM analyses were performed
on the normalized GM and WM segments. Finally, the
images were smoothed with a Gaussian kernel of 8 mm full
width at half maximum (FWHM). Voxel-wise GM differences
between OPVHs and the CN group were examined using
the independent-sample t-test. To avoid possible edge effects
between different tissue types, we excluded all voxels with
GM values of less than 0.09 (absolute threshold masking). We
also applied a threshold of p < 0.001 with 30-voxel clustering
criteria and family-wise error rate (FEW) correction to eliminate
potential type I errors. Age was used as a nuisance effect.
Multiple regression VBM analysis was performed to explore
the relationship between the MRI results and the clinical
factors.
RESULTS
Clinical Factors of the OPVHs Patients and
CN
Table 1 summarizes the clinical factors of the OPVHs patients
and CN. Chi-square test and Student’s t-test showed that TC,
LDL-C and Apo-B were significantly lower in the OPVHs
patients than the CN (p < 0.05). The OPVHs patients
were significantly older than the CN. It should be noted
that Gen, CS, DM, CAU and Htn showed no significant
differences.
Comparison Between MRI Results of
OPVHs Patients and CN
Figure 1 shows the comparison between two typical T2-weighted
MRI images obtained from a OPVHs patient and a CN.
1http://www.fil.ion.ucl.ac.uk/spm
2http://dbm.neuro.uni-jena.de/vbm.html
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TABLE 1 | Differences in clinical risk factors between OPVHs patients and
CN.
Group OPVHs CN χ2/t p
n 97.00 73.00
Gen (n, %male)1 61 (62.89) 35 (47.95) 3.78 0.05
Age (years)2 71.79 (8.29) 68.9 (7.91) −4.87 0.00∗
Fazekas score 2.73 (0.54) 0.0 (0.00) \ \
CS (n, %)1 24 (24.74) 21 (28.77) 0.35 0.56
CAU (n, %)1 21 (21.65) 14 (19.18) 0.16 0.69
Htn (n, %)1 47 (48.45) 26 (35.62) 2.80 0.09
DM (n, %)1 18 (18.56) 8 (10.96) 1.86 0.17
TC2 4.61 (1.07) 4.81 (0.96) 2.05 0.04∗
TG2 1.44 (0.76) 1.66 (1.17) 1.48 0.14
LDL_C2 2.51 (0.63) 2.83 (0.68) 3.20 0.00∗
HDL_C2 1.34 (0.32) 1.29 (0.30) −0.95 0.34
UA2 289 (75.30) 277.75 (67.33) −1.01 0.31
Apo-A12 1.30 (0.31) 1.25 (0.33) −1.01 0.31
Apo-B2 0.84 (0.24) 0.91 (0.23) 2.24 0.03∗
Data are presented as the means (standard deviation). Chi-square tests and
Student’s t-test were used to determine significant differences in the frequencies
of categories and differences in continuous variables, respectively, between the
groups. TC, LDL-C and Apo-B were significantly lower in the OPVHs patients
compared to the CN (p < 0.05). Regarding age, OPVHs patients were significantly
older than the CN. It should be noted that the Gen, CS, DM, CAU, and Htn
had no significant differences. Abbreviations are as follows: OPVHs, occipital
periventricular hyperintensities; CN, healthy controls, Gen, gender; CS, current
smoking; CAU, current alcohol use, Htn, hypertension; DM, diabetes mellitus;
TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol;
HDL-C, high-density lipoprotein cholesterol; UA, uric acid; Apo-A1, apolipoprotein-
A1; and Apo-B, apolipoprotein-B; 1,2,∗denote chi-square test, Student’s t-test and
p < 0.05, respectively.
WMHs were bright with higher signal intensities. Note that no
subjects had cerebral infarcts defined as focal hyperintensities
on T2 images. Figure 2 and Table 2 show the VBM results:
OPVHs patients had significantly reduced GM in the right
supramarginal gyrus, right angular gyrus, right middle temporal
gyrus, right anterior cingulum and left insula compared to
FIGURE 1 | Two typical T2-weighted Magnetic resonance imaging
(MRI) images obtained from a occipital periventricular hyperintensities
(OPVHs) patient (A) and a healthy control (CN) (B). White matter
hyperintensities (WMHs) were bright with higher signal intensities (A). Note that
subjects had cerebral infarcts, defined as focal hyperintensities on T2 images.
TABLE 2 | VBM results of the gray matter atrophy in OPVHs patients
compared with CN.
Brain area T MNI coordinate
x y z
Right supramarginal gyrus 4.620 33.0 −39.0 40.5
Right angular gyrus 4.087 55.5 −31.5 30.0
Left insula 4.235 −36.0 21.0 −3.0
Right middle temporal lobe 4.260 39.0 −48.0 40.5
Right anterior cingulum 3.740 1.5 34.5 18.0
Left temporal lobe 3.525 −24.0 33.0 34.5
Differences in brain regions were obtained by subtracting the results for the
OPVHs patients from those of the CNs using the two independent samples t-test
(p < 0.001, uncorrected, with a clustering criteria of voxels > 30). OPVHs patients
had significantly reduced gray matter in the right supramarginal gyrus, right angular
gyrus, right middle temporal gyrus, right anterior cingulum and left insula compared
to the CN. Abbreviations are as follows: MNI coordinates, Montreal Neurological
institute coordinates.
the CN (P < 0.001, uncorrected, with 30-voxel clustering
criteria).
Multiple Regression VBM Analyses
For multivariate statistics, a p value of less than 0.05 in
the univariate analysis was applied. Age and OPVHs as well
as TC and LDL-C were strongly colinear in an orthogonal
design; thus, only Fazekas score, LDL-C and Apo-B were
applied for subsequent multivariate regression analyses. The
reduced GM volumes of the left precentral gyrus and insula
cortex were correlated with Fazekas score, LDL-C and Apo-B
(p < 0.05, family-wise error (FSE)-corrected with 30-voxel
clustering criteria; Table 3, Figures 3, 4).
DISCUSSION
OPVHs, a subgroup ofWMHs, are frequently observed in elderly
subjects (de Leeuw et al., 2001). Age and Htn have been reported
to be the most common risk factors for WMHs (Liao et al.,
1997; de Leeuw et al., 2002; Popa-Wagner et al., 2014, 2015;
Pantoni et al., 2015), while hyperlipidemia, smoking, high body
mass index, decreased vitamin B12 and alcohol may also be
associated with WMHs (Breteler et al., 1994; Longstreth et al.,
1996; Liao et al., 1997; Jeerakathil et al., 2004; Hickie et al., 2005;
Murray et al., 2005; Stenset et al., 2006). Our study showed that
Age, TC, LDL-C and Apo-B were statistically different between
TABLE 3 | Brain area of OPVHs with significance in multivariate regression
analyses.
Brain area T MNI coordinate
x y z
Left precentral gyrus 7.910 −30.000 −40.500 −6.000
Left insula cortex 7.630 −33.000 15.000 9.000
Gray matter atrophy was found in the left precentral gyrus and insula cortex
of patients with OPVHs in a multivariate regression analysis (p < 0.05,
FWE-corrected, with 30-voxel clustering criteria).
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FIGURE 2 | Voxel-based morphometry (VBM) results of gray matter (GM) atrophy in OPVHs patients compared with CN. (A) Statistical parametric
mapping (SPM) results in various brain regions. (B) GM atrophy was found in the right supramarginal gyrus, right angular gyrus, right middle temporal gyrus, right
anterior cingulum and left insula compared to the CN (P < 0.001, uncorrected, with 30-voxel clustering criteria).
OPVHs group and CN group, OPVHs group had older age and
lower TC, LDL-C and Apo-B compared with CN. Although the
mechanism for the inverse correlation between TC, LDL-C and
Apo-B and OPVHs is not fully understood, it should be noted
that cholesterol may play an important role in neuron repair and
remodeling in the central nervous system (Dietschy, 2009). Thus,
the reduced cholesterol level may contribute to the reduction
in WM.
Previous studies showed that WMHs have been associated
with a number of adverse outcomes, including cognitive
FIGURE 3 | Significant brain area of OPVHs in multivariate regression analyses. (A) SPM results in various brain regions. (B) 3D brain map. GM atrophy was
found in the left precentral gyrus and left insula cortex of patients with OPVHs in a multivariate regression analysis (P < 0.05, FWE-corrected, with 30-voxel clustering
criteria).
Frontiers in Aging Neuroscience | www.frontiersin.org 4 September 2016 | Volume 8 | Article 214
Duan et al. Gray Matter Atrophy of OPVHs
FIGURE 4 | Scatter plots of the relationship between potential clinical risk factors and the reduced GM in OPVHs patients. (A) Scatter plots of the
relationship between potential clinical risk factors and reduced GM in the left precentral gyrus. (B) Scatter plots of the relationship between potential clinical risk
factors and reduced GM in left insula cortex. The reduced GM volume of the left precentral gyrus and insula cortex were correlated with Fazekas score, low-density
lipoprotein cholesterol (LDL-C) and apolipoprotein-B (Apo-B).
impairment, functional disability or even death (Scott et al.,
2015; Yamawaki et al., 2015; Abraham et al., 2016). Additionally,
the total volume and location of WMHs are important
determinants of the clinical relevance (Swartz et al., 2003;
Yoshita et al., 2006; Biesbroek et al., 2013). Visual and
automated rating scales have been developed to assess the
severity of WMHs (Fazekas et al., 1987; Scheltens et al., 1993;
Gouw et al., 2006; Maillard et al., 2008; Maldjian et al.,
2013). Two lesion subtypes have been proposed based on
their proximity to the ventricles. These include PV lesions,
which are contiguous with the ventricles, as well as DWMHs
lesions, which are distinct and separate from the ventricles
(Fazekas et al., 1993; Enzinger et al., 2006; Spilt et al.,
2006; Rostrup et al., 2012). These lesion classifications have
been supported by previous studies (Zhang et al., 2013).
However, the cognitive impairment associated with WMHs
may also depend on brain reserve (Brickman et al., 2011;
Murray et al., 2011; Freret et al., 2015). WMHs and brain
atrophy often coexist in the elderly (Aribisala et al., 2013).
However, few studies have investigated GM atrophy in
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OPVHs patients. Our results demonstrate that GM atrophy
occurred in the right supramarginal gyrus, right angular gyrus,
right middle temporal gyrus, right anterior cingulum and
left insula in OPVHs patients. These results are consistent
with previous studies (Sepulcre et al., 2009; Raji et al.,
2012).
Shared vascular risk factors may be an explanation for their
concomitance. One explanation that has been proposed is
that an impaired autoregulation due to the microangiopathy
in combination with the luminal narrowing reduces the
cerebral blood flow (Waldemar et al., 1994) and induce
OPVHs. The hippocampus and amygdala are sensitive
to hypoxia and ischemia (Pulsinelli et al., 1982; Cervós-
Navarro and Diemer, 1991), which may lead to neuronal
loss in these brain structures (Kril et al., 2002). However,
disturbances of WM integrity could also be involved in the
pathogenesis of brain atrophy. Our results showed that the
left precentral gyrus and left insula cortex were correlated
with Fazekas score, LDL-C and Apo-B. Notably, LDL-
C and Apo-B are independently correlated with reduced
voxels; however, their roles could not be determined.
One possible mechanism is the loss of myelin, axons, and
oligodendrocytes and other glial cells in the WM as a result
of ischemic damage due to the underlying small-vessel disease
(Pantoni and Garcia, 1997; von Bohlen und Halbach and
Unsicker, 2002; Du et al., 2005). Another possibility is that
WMHs influence GM with projecting tracts that modulate
neurotransmitters (Bocti et al., 2005; Behl et al., 2007; Kim et al.,
2012).
Our study was conducted using a cross-sectional design based
in a hospital and had a relatively small sample size. A specifically
designed, randomized, controlled prospective population-based
study is warranted in the future. Future studies may also assess
the role between OPVHs, LDL-C and Apo-B in GM atrophy in a
potential mechanistic study.
CONCLUSION
OPVHs patients had significantly reduced GM in the right
supramarginal gyrus, right angular gyrus, right middle temporal
gyrus, right anterior cingulum and left insula compared
to healthy controls. Additionally, OPVHs patients had GM
atrophy in the left precentral gyrus and left insula cortex,
and such atrophy is associated with a reduction in LDL-C
and Apo-B. OPVHs may lead to cerebral atrophy related to
cognitive impairment. Future studies exploring the structural
foundations of human cognitive impairment may benefit from
our study.
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